CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

Original languageEnglish
JournalLeukemia and Lymphoma
Volume63
Issue6
Pages (from-to)1479-1483
Number of pages5
ISSN1042-8194
DOIs
Publication statusPublished - May 2022

See relations at Aarhus University Citationformats

ID: 278011186